Trial Profile
Phase 3 study of JTT-751 for treatment of patients with hyperphosphatemia on peritoneal dialysis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Ferric citrate (Primary)
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- 25 Nov 2015 New trial record